XSHE
002124
Market cap736mUSD
Jul 10, Last price
2.31CNY
1D
2.67%
1Q
-1.70%
Jan 2017
-56.76%
IPO
41.35%
Name
Tech-bank Food Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Tech-Bank Food Co., Ltd., along with its affiliated entities, operates extensively within the agricultural and animal husbandry sectors, conducting business both domestically in China and internationally. The company's operations are diversified across five principal divisions: Aquatic Feed, Biological Products, Pig-Breeding, Fresh Food, and Engineering Construction. Its Aquatic Feed segment focuses on producing and distributing feed for a wide variety of aquatic animals, including shrimp, crabs, turtles, frogs, and fish, in addition to supplying environmentally friendly food production materials. The Biological Products division is dedicated to developing and providing specialized animal vaccines, such as the pathogenic PRRS cell suspension culture heat-resistant protective agent live vaccine (JAX1-R Strain) and the avian influenza (H9) cell suspension inactivated vaccine, serving the animal health industry, and also offers livestock and poultry products. Tech-Bank Food's Pig-Breeding operations include the provision of genetic products for pigs. Moreover, its Fresh Food segment delivers a diverse array of gourmet items, such as caviars, hairy crabs, crystal shrimps, and yellow croaker products, complemented by its activities in pork and seafood processing. Finally, the Engineering Construction division offers end-to-end services encompassing the planning, design, construction, and management of various projects. Established in 1996 and headquartered in Shanghai, China, the company underwent a name change in May 2017, transitioning from its former identity as Ningbo Tech-Bank Co., Ltd. to its current designation, Tech-Bank Food Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2019‑00 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||||
Revenues | |||||||||||||
Cost of revenue | |||||||||||||
Unusual Expense (Income) | |||||||||||||
NOPBT | |||||||||||||
NOPBT Margin | |||||||||||||
Operating Taxes | |||||||||||||
Tax Rate | |||||||||||||
NOPAT | |||||||||||||
Net income | |||||||||||||
Dividends | |||||||||||||
Dividend yield | |||||||||||||
Proceeds from repurchase of equity | |||||||||||||
BB yield | |||||||||||||
| Debt | |||||||||||||
Debt current | |||||||||||||
Long-term debt | |||||||||||||
Deferred revenue | |||||||||||||
Other long-term liabilities | |||||||||||||
Net debt | |||||||||||||
| Cash flow | |||||||||||||
Cash from operating activities | |||||||||||||
CAPEX | |||||||||||||
Cash from investing activities | |||||||||||||
Cash from financing activities | |||||||||||||
FCF | |||||||||||||
| Balance | |||||||||||||
Cash | |||||||||||||
Long term investments | |||||||||||||
Excess cash | |||||||||||||
Stockholders' equity | |||||||||||||
Invested Capital | |||||||||||||
ROIC | |||||||||||||
ROCE | |||||||||||||
| EV | |||||||||||||
Common stock shares outstanding | |||||||||||||
Price | |||||||||||||
Market cap | |||||||||||||
EV | |||||||||||||
EBITDA | |||||||||||||
EV/EBITDA | |||||||||||||
Interest | |||||||||||||
Interest/NOPBT | |||||||||||||